Gingivitis
Clinical Snapshot
Gingivitis is inflammation of the gingiva (gum tissue) triggered by bacterial biofilm — dental plaque — accumulating at and just below the gumline. Bacterial byproducts in the plaque provoke a local host inflammatory response: the gingival blood vessels dilate and become more permeable, producing the redness, swelling, and easy bleeding that define the condition.[1] If plaque is not disrupted daily by brushing and flossing, it mineralizes into tartar (calculus) within days, which only professional instrumentation can remove and which itself becomes a further plaque-retentive, inflammation-perpetuating surface.[1][2]
Gingivitis is the earliest and mildest stage of periodontal disease — and the only stage that is genuinely reversible. By definition it involves inflammation confined to the gingiva, with no loss of the connective-tissue attachment or supporting bone that anchors the tooth. The internationally adopted 2018 AAP/EFP classification of periodontal diseases formalizes this: gingival health is bleeding on probing at <10% of sites, gingivitis is bleeding on probing at 10% of sites or more (subdivided into localized, 10-30% of sites, and generalized, over 30%), and both categories require a probing depth no greater than 3 mm with no attachment loss. Periodontitis, by contrast, is defined by measurable attachment loss and is not reversible in the same way — a distinction developed fully in Recognize the Condition, because it determines whether a case belongs in a pharmacy consult at all.[3]
Gingivitis is extremely common. The Canadian Dental Association states that 7 out of 10 Canadians will develop gum disease at some point in their lives, making it the most common dental problem seen in practice.[2] The American Dental Association similarly describes gingivitis as very common, including among children, and notes that at this stage "the disease is still reversible" with a professional cleaning plus daily brushing and flossing.[4] Left untreated, gingivitis can — though does not always — progress to periodontitis, at which point the disease is no longer confined to reversible soft-tissue inflammation and is far more prevalent than most patients realize: the ADA reports that chronic periodontitis affects 47.2% of American adults over age 30.[5] This progression risk, not the gingivitis itself, is what makes early recognition and genuinely effective counselling worthwhile.[1][3]
The single most useful thing to communicate to a patient with gingivitis is also the most reassuring: unlike periodontitis, gingivitis is fully reversible. Consistent mechanical plaque removal — proper brushing, daily interdental cleaning, and regular professional cleaning — can restore healthy, non-bleeding gingiva within days to a few weeks. Everything else in this chapter, including mouth rinses, is an adjunct to that foundation, not a replacement for it.
Recognize the Condition
What patients report
Patients typically notice blood on their toothbrush or in the sink after brushing, gums that look redder or puffier than usual, or mild tenderness — but importantly, gingivitis is usually painless, which is precisely why it is so often ignored until a dental visit or a pharmacist raises it.[1][4] Some patients report bad breath, though persistent halitosis despite good hygiene is more suggestive of periodontitis and is covered in Red Flags and Referral.
What you find on examination
Look for gingival erythema (redness) and edema (swelling), loss of the normal stippled ("orange-peel") texture of healthy gingiva, rounded or bulbous rather than knife-edged interdental papillae, and bleeding on gentle probing or brushing. Healthy gingiva is firm, pale pink (allowing for normal physiologic pigmentation), and does not bleed with routine brushing.[1][3] Visible plaque and supragingival calculus at the gumline are common accompanying findings and are themselves part of the diagnosis, not just a risk factor.[2]
Differentiating gingivitis from periodontitis — the key clinical distinction
This is the single most important judgment call in this chapter, because it determines whether a case is appropriate for hygiene-focused counselling or needs referral for formal periodontal management. Gingivitis is inflammation without attachment loss or bone loss; periodontitis is inflammation with progressive, measurable loss of the connective-tissue attachment and supporting alveolar bone.[3] Under the 2018 AAP/EFP classification, a periodontitis diagnosis specifically requires interproximal clinical attachment loss at two or more non-adjacent teeth, or buccal/lingual attachment loss of 3 mm or more with pocketing of 3 mm or more, at two or more teeth.[3] A pharmacist cannot measure attachment loss or true periodontal pocket depth — that requires a dental periodontal probe and training — but the history and visible findings below reliably flag when a case is not simply gingivitis and needs that formal assessment.
| Feature | Gingivitis | Periodontitis |
|---|---|---|
| Attachment loss / bone loss | None | Present and progressive — the defining feature |
| Probing depth | ≤3 mm | Often >3 mm with true pocket formation |
| Gum recession or tooth mobility | Absent | Can be present, especially in advanced disease |
| Reversibility | Fully reversible with plaque control | Not reversible — attachment/bone lost is not regenerated by treatment |
| Long-term status | Can return completely to gingival health | "A periodontitis patient remains a periodontitis patient for life," requiring lifelong supportive care even after successful treatment |
| Typical management | Improved home care plus a routine professional cleaning | Formal periodontal therapy (scaling and root planing, possible surgery) and ongoing periodontal maintenance under a dentist or periodontist |
Why this distinction matters practically: recommending "just brush and floss more" to a patient who actually has undiagnosed periodontitis under-treats a progressive disease, while correctly identifying straightforward gingivitis lets a pharmacist give confident, genuinely effective self-care advice without over-referring every case of gum bleeding. See Red Flags and Referral for the specific findings that should prompt a periodontal referral rather than routine gingivitis counselling.
Risk Factors
Poor oral hygiene — the primary driver
Inadequate or infrequent brushing and flossing is the dominant cause of gingivitis in almost every case: without daily mechanical disruption, plaque biofilm accumulates and matures into calculus, and the resulting bacterial load simply outpaces the gingiva's ability to stay uninflamed.[1][2] Every other risk factor below acts by increasing bacterial burden, altering the host inflammatory response, or both — poor hygiene remains the common final pathway.
Smoking
Tobacco use is identified by the Canadian Dental Association as a major risk factor for gum disease and other dental complications, both by directly impairing gingival blood supply and healing and by promoting plaque accumulation.[1] Practically important: nicotine-related vasoconstriction may reduce the visible bleeding on probing that pharmacists and dentists rely on as a warning sign, so smokers can have meaningfully inflamed gingiva with a deceptively unremarkable-looking exam — the mechanistic evidence for this specific vasoconstriction pathway in humans is not fully conclusive, but the clinical observation of masked bleeding in smokers is well described, and it argues for closer attention in smokers, not less.[6]
Diabetes — a genuinely bidirectional relationship
Diabetes is one of only two factors (along with smoking) formally recognized as a true risk factor for periodontal disease in the 2018 AAP/EFP classification.[7] The relationship runs both ways: poorly controlled diabetes worsens gingival and periodontal inflammation, and that inflammation in turn can worsen glycemic control — a genuinely bidirectional link that has been described in the literature for over 20 years.[7] Diabetes now affects more than 8% of Canadians, a 37.3% increase in prevalence over the preceding decade according to Public Health Agency of Canada surveillance data, making this a common and clinically relevant intersection in everyday pharmacy practice.[7] It is worth being precise with patients about the strength of this relationship: a 2021 Canadian Dental Hygienists Association position paper reviewing the highest-quality evidence found consistent but small reductions in HbA1c (averaging 0.26% to 0.65% across five systematic reviews/meta-analyses) at 3 months following non-surgical periodontal therapy, with the effect not clearly sustained at 6 months — real, but modest, and not a substitute for standard diabetes management.[7] The clinically useful takeaway is the recommendation that patients with diabetes and any degree of periodontal inflammation have professional periodontal maintenance at intervals no longer than 3 months, rather than the standard 6-12 months.[7]
Pregnancy — hormonal gingivitis
Pregnancy-associated (hormonal) gingivitis is a recognized and common entity, not a minor curiosity: gingivitis is reported to affect 60% to 75% of pregnant women, driven by fluctuating estrogen and progesterone levels acting together with changes in oral flora and a somewhat blunted local immune response.[8] About half of women with pre-existing gingivitis experience a significant exacerbation during pregnancy.[8] See Special Populations for management specifics.
Medications causing gingival hyperplasia — a genuinely pharmacist-relevant point
Three drug classes are well established causes of drug-induced gingival overgrowth (gingival hyperplasia), through a shared mechanism involving disturbed fibroblast calcium/folate handling that drives excess collagen deposition in the gingiva[9]:
- Phenytoin (phenytoin) — the anticonvulsant prototype, with gingival overgrowth reported in up to 50% of patients on long-term therapy.[9]
- Cyclosporine (cyclosporine) — the calcineurin-inhibitor immunosuppressant most often implicated, particularly common in solid-organ transplant recipients, with overgrowth reported in roughly 30% of patients.[9]
- Calcium channel blockers, especially dihydropyridines such as nifedipine and amlodipine — reported in roughly 20% of patients on nifedipine, with amlodipine first documented to cause the same effect in 1994.[9]
These three classes are not interchangeable in tissue appearance: phenytoin-induced overgrowth tends to be predominantly fibrotic, cyclosporine-induced overgrowth tends to be more inflamed with less fibrosis, and calcium-channel-blocker-induced overgrowth is typically a mixed picture — but for pharmacist purposes, the practical point is the same across all three: recognize the pattern, do not stop the drug unilaterally, and see Choose Initial Treatment and Special Populations for the actual management approach.[9]
Xerostomia-causing medications — an indirect but real contributor
Saliva plays a genuine protective role against gingival inflammation, not only against caries: it buffers plaque acids, supplies antibacterial and antifungal proteins, and provides mechanical clearance of food debris and bacteria from the gumline.[10] Medications that reduce salivary flow — anticholinergics, many antihistamines, tricyclic antidepressants, and others covered in this platform's Dry Mouth chapter — can therefore indirectly worsen gingival health by removing much of this protective effect, on top of whatever direct oral-hygiene barriers a patient may already face.[10] A xerostomia complaint is a reasonable prompt to also ask about gingival bleeding, and vice versa.
Red Flags & Refer
Most gum bleeding a pharmacist sees is straightforward plaque-induced gingivitis that responds well to the self-care measures in this chapter. The findings below point to periodontitis, a more urgent infection, or a medication effect that needs dental or prescriber involvement rather than routine gingivitis counselling.
- Gum recession, tooth mobility, or purulent (pus) discharge from the gumline — none of these are features of simple gingivitis and all suggest periodontitis with true attachment loss; refer for a formal periodontal assessment rather than recommending hygiene measures alone.[3]
- Persistent bad breath despite genuinely good oral hygiene — ordinary gingivitis is not typically associated with refractory halitosis; this pattern also points toward periodontitis or true periodontal pocketing.[2]
- Severe pain, rapid onset, punched-out or cratered interdental papillae covered by a grey pseudomembrane, fetid ("metallic" or foul) breath, and possible fever, malaise, or swollen lymph nodes — this is necrotizing (ulcerative) gingivitis, a distinct and more urgent condition, not ordinary gingivitis. Predisposing factors include psychological stress, smoking, pre-existing gingivitis, poor nutrition, and immunocompromise (including HIV infection).[11] Management is professional debridement over several days, home rinsing with 0.12% chlorhexidine gluconate twice daily (or salt water/hydrogen peroxide as supportive measures), analgesia, and systemic antibiotics — amoxicillin-clavulanate or metronidazole — when fever or malaise are present; dramatic improvement is typical within days of appropriate treatment, but this needs a dentist, not a pharmacy self-care recommendation.[11] Refer urgently.
- Gingival overgrowth in a patient taking phenytoin, cyclosporine, or a calcium channel blocker that is severe, disfiguring, or interfering with eating or oral hygiene — raise a medication-review conversation with the prescriber (see Special Populations); severe cases may ultimately need surgical gingivectomy, which is a dental referral, not a pharmacy intervention.[9]
- Gingivitis that does not improve after 2-4 weeks of genuinely consistent brushing, flossing, and a completed professional cleaning — reassess for unrecognized periodontitis or another contributing cause rather than assuming the self-care plan simply needs more time (see Treatment Failure/Next Step).
- Gum bleeding that seems disproportionate to the degree of visible plaque/inflammation, or that is accompanied by bruising elsewhere, unusual fatigue, or other bleeding symptoms — consider a systemic contributor (anticoagulant or antiplatelet therapy, a bleeding disorder, vitamin C deficiency, or a hematologic condition) rather than assuming routine gingivitis, and refer appropriately.
Assessment & Diagnosis
History
Ask about the pattern and duration of bleeding (with brushing only, or also spontaneous), pain (gingivitis is typically painless — significant pain is itself a red flag), current brushing/flossing habits and frequency, time since the last professional dental cleaning, smoking status, pregnancy status, diabetes history and control, and a complete medication list with specific attention to phenytoin, cyclosporine, and calcium channel blockers.[1][9]
Examination
Assess gingival colour, contour, and consistency, and look specifically for the findings described in Recognize the Condition: erythema, edema, loss of stippling, rounded papillae, and bleeding on gentle probing or brushing, together with visible plaque and calculus.[1] Equally important is a targeted look for what should not be present in simple gingivitis: gum recession, visibly loose teeth, purulent discharge, or deep-looking pocketing — any of which shift the case toward Red Flags and Referral rather than routine counselling. A formal periodontal probing examination (measuring true attachment loss and pocket depth) is outside pharmacy scope and requires referral when the history or exam is ambiguous.[3]
The Loe and Silness Gingival Index — a teaching reference, not a pharmacy diagnostic tool
Dental professionals commonly grade gingivitis severity using the Loe and Silness Gingival Index, reproduced here from the Health Canada-approved chlorhexidine gluconate 0.12% product monograph as a teaching reference for understanding how a dentist or hygienist is likely describing a patient's disease severity — it is not intended for pharmacists to score independently.[12]
| Grade | Description |
|---|---|
| 1 | Normal gingiva — no inflammation, no discolouration, no bleeding |
| 2 | Mild inflammation — slight colour change, mild alteration of the gingival surface, no bleeding |
| 3 | Moderate inflammation — erythema, swelling, bleeding on probing or when pressure is applied |
| 4 | Severe inflammation — marked erythema and swelling, tendency toward spontaneous hemorrhage, some ulceration |
When to pursue further assessment
Straightforward gingivitis with an obvious hygiene-related cause and none of the Red Flags and Referral findings does not need further workup — the "investigation" is the history and visual exam described above, and the treatment is the plan in Choose Initial Treatment. Pursue dental referral for a formal periodontal assessment whenever attachment loss, recession, mobility, pocketing, refractory halitosis, or a lack of response to good self-care after 2-4 weeks is present.[3]
Treatment Targets
- Resolve gingival inflammation and restore healthy pink, firm, non-bleeding gingiva.
- Achieve this through consistent mechanical plaque removal, since gingivitis is fully reversible with adequate hygiene — the goal is genuine resolution, not just symptomatic improvement.
- Prevent progression to periodontitis, which is not reversible in the same way and requires lifelong periodontal maintenance once established.
- Identify and appropriately manage modifiable contributors — smoking, suboptimal glycemic control in diabetes, and a causative medication where one is present — rather than treating symptoms in isolation from their cause.
- Recognize and refer promptly any presentation that is not simple gingivitis: signs of periodontitis, necrotizing gingivitis, or severe medication-induced gingival hyperplasia.
- Use mouth rinses correctly, as adjuncts to mechanical plaque removal rather than substitutes for it, and set realistic expectations about duration of use and side effects (particularly for chlorhexidine) to support adherence.
Choose Initial Treatment
Mechanical plaque removal comes first — every time
Before recommending any mouth rinse, confirm the patient is brushing correctly twice daily and cleaning interdentally once daily, and confirm when they last had a professional cleaning to remove any calculus a toothbrush cannot touch. Most straightforward gingivitis begins to improve within days and substantially resolves within 1-2 weeks of consistent, correct mechanical plaque control plus a completed professional cleaning — a mouth rinse is an adjunct on top of this foundation, never a substitute for it.[1][2]
Build the plan in this order
Step 1 — every patient correct brushing technique with a soft-bristled brush twice daily, daily interdental cleaning (floss, interdental brushes, or a water flosser for patients who will not floss), and a professional scaling appointment to remove any tartar/calculus — see Non-Pharmacologic Management.[1]
Step 2 — bleeding/inflammation persists after 1-2 weeks of confirmed good technique, or short-term support is needed (for example, immediately post-scaling, or during a period of reduced hygiene such as with fixed orthodontic appliances) add chlorhexidine gluconate 0.12% oral rinse, 15 mL rinsed for 30 seconds twice daily after brushing, as part of a dentist- or prescriber-directed initial 3-month course.[12] Counsel proactively on reversible tooth/tongue staining and taste alteration before the patient starts — this is the single most common reason for early, avoidable discontinuation.[12]
Step 2, alternative — mild gingivitis, or ongoing maintenance once inflammation is controlled an OTC essential-oil rinse (thymol/eucalyptol/menthol-type) or a cetylpyridinium chloride rinse is a reasonable adjunct with genuine supporting evidence; comparative trials show essential-oil rinses with a modest edge over cetylpyridinium chloride at 3 and 6 months, though both meaningfully reduce plaque and gingivitis versus no rinse.[13] Neither replaces brushing and flossing.
Suspected causative medication (phenytoin, cyclosporine, a calcium channel blocker) or pregnancy-associated gingivitis reinforce mechanical plaque control as first-line in both situations; for a suspected drug cause, raise a medication-review conversation with the prescriber rather than adjusting the drug independently (see Special Populations); for pregnancy-associated gingivitis, expect substantial improvement to continue through more frequent professional cleaning and largely resolve postpartum.[9][8]
Suspected necrotizing gingivitis, periodontitis, or severe/refractory gingival hyperplasia refer to dentistry — see Red Flags and Referral. These are not managed with routine gingivitis self-care.
Non-Pharmacologic Treatment
- Correct brushing technique — a soft-bristled (manual or power) toothbrush, angled toward the gumline, used for a full two minutes twice daily; this is the genuine foundation of treatment and the first thing to confirm before recommending anything else.[1][2]
- Daily interdental cleaning — floss, interdental brushes, or a water flosser for patients who will not reliably floss; plaque between teeth is not reached by brushing alone and is a common site of persistent inflammation when this step is skipped.[1]
- Regular professional dental cleaning (scaling) — the only way to remove calculus (mineralized plaque) once it has formed; this is core therapy, not an optional extra, since no amount of home brushing removes established tartar.[1][2]
- Routine dental check-ups so early warning signs are caught and any progression toward periodontitis is identified before it becomes irreversible.[1]
- Smoking cessation counselling — genuinely relevant here given smoking's role both in worsening gingival inflammation and in masking its most visible warning sign (bleeding).[1][6]
- Glycemic optimization in patients with diabetes, as a genuine adjunct to (not a replacement for) mechanical plaque control, given the bidirectional relationship described in Risk Factors.[7]
- For denture or orthodontic-appliance wearers: reinforce appliance-specific hygiene, since these are genuinely plaque-retentive and can perpetuate localized gingival inflammation despite otherwise reasonable technique.
Special Populations
Pregnancy
Hormonal (pregnancy-associated) gingivitis affects an estimated 60% to 75% of pregnant women, driven by fluctuating estrogen and progesterone acting together with altered oral flora and a somewhat blunted local immune response; roughly half of women with pre-existing gingivitis notice significant worsening during pregnancy.[8] Reinforce mechanical plaque control as first-line, and encourage additional professional cleanings during pregnancy since dental procedures including periodontal treatment are considered safe throughout pregnancy and are best timed to the second trimester when practical.[8] Chlorhexidine in pregnancy reproduction/fertility studies in animals showed no evidence of fetal harm at doses far exceeding typical human exposure from rinsing, but controlled studies in pregnant women have not been conducted — the Health Canada product monograph directs that the benefits of use in pregnancy be weighed against any possible risk on an individual basis, in consultation with the dental/prescribing team.[12] Expect substantial improvement to continue postpartum as hormone levels normalize, though persistent severe cases still warrant dental reassessment rather than being assumed to be self-limiting indefinitely.
Diabetes
Diabetes is one of only two true risk factors for periodontal disease (with smoking), and the relationship with gingival/periodontal inflammation is genuinely bidirectional.[7] Reinforce that gingival/periodontal care is a genuine adjunct to glycemic management, not a substitute for it, and that current Canadian evidence supports periodontal maintenance visits no less often than every 3 months for patients with diabetes and any degree of gingival or periodontal inflammation, rather than the usual 6-12 month interval.[7] Set expectations honestly: periodontal therapy produces a real but modest HbA1c benefit (roughly 0.26-0.65% at 3 months in the best available evidence), not a substitute for standard diabetes therapy.[7]
Pediatrics
Gingivitis is reported by the American Dental Association to be very common among children.[4] Supervise and reinforce brushing technique in young children, who often lack the fine motor skills for effective plaque removal on their own, and confirm interdental cleaning is actually happening rather than assumed. Fixed orthodontic appliances are a common, genuinely plaque-retentive risk factor in this age group and warrant reinforced technique specific to the appliance. Chlorhexidine's safety and efficacy in children has not been fully established — the Health Canada monograph directs that its use in children be weighed against possible risks on an individual, dentist-directed basis rather than recommended routinely.[12]
Patients on phenytoin, cyclosporine, or a calcium channel blocker
Reinforce that meticulous plaque control measurably reduces the severity of drug-induced gingival hyperplasia even when the causative drug cannot be changed.[9] Never suggest stopping or switching an anticonvulsant, immunosuppressant, or antihypertensive unilaterally for a gingival reason — raise it as a medication-review conversation with the prescriber, who can weigh whether an alternative agent within the same therapeutic class is appropriate for that patient. Severe, disfiguring, or functionally limiting overgrowth despite good plaque control may ultimately need surgical gingivectomy, which is a dental referral.[9]
Smokers
Reduced visible bleeding on probing in smokers can mask the usual clinical warning sign of gingivitis, so a reassuring-looking exam in a smoker should not be taken at face value; combine visual assessment with a careful history and consider a slightly lower threshold for professional dental reassessment in this group.[6]
Older adults
Consider cumulative xerogenic medication burden as a contributor to gingival health in this group — reduced salivary flow removes much of saliva's protective buffering and antibacterial effect, on top of any manual-dexterity barriers to effective brushing/flossing (for example, from arthritis).[10] See this platform's Dry Mouth chapter for the medication-review approach to xerostomia itself.
Monitoring & Follow-Up
- Reassess gingival colour, firmness, and bleeding at every follow-up; expect visible improvement within days to a week of consistent correct technique plus a completed professional cleaning, and substantial resolution within about 2-4 weeks.[1]
- For patients using chlorhexidine gluconate 0.12% rinse: confirm the planned dental recall at the end of the initial 3-month course, at which point the dental team evaluates progress, removes any stain, and decides whether to discontinue (inflammation controlled) or continue for a further 3 months (inflammation still present) — this is not intended as an indefinite daily rinse.[12]
- For pregnancy-associated gingivitis: confirm more frequent professional cleanings are actually happening, and specifically ask at postpartum follow-up whether gingival health has improved as expected — persistence should prompt dental reassessment rather than being assumed to be self-resolving indefinitely.[8]
- For patients with diabetes: confirm periodontal maintenance visits are occurring at intervals no longer than 3 months, and reinforce that this is about periodontal health, not a mechanism for controlling HbA1c on its own.[7]
- For patients on phenytoin, cyclosporine, or a calcium channel blocker: track gingival overgrowth severity at routine visits/refills, and flag any progression for the medication-review conversation described in Special Populations.[9]
- Screen for the Red Flags and Referral findings (recession, mobility, purulence, refractory halitosis) at every follow-up, since these signal a shift from simple gingivitis to periodontitis that needs a different management pathway entirely.
Common Errors to Avoid
- Recommending a mouth rinse — chlorhexidine or an OTC alternative — as a substitute for brushing and flossing rather than as an adjunct to it.[1]
- Recommending or allowing indefinite, unsupervised daily chlorhexidine use rather than the directed, time-limited course (an initial 3 months, then dental reassessment) it is actually approved for.[12]
- Not warning patients in advance about chlorhexidine's staining and taste-alteration effects — a common, avoidable cause of early discontinuation when it comes as an unexpected surprise.[12]
- Assuming any gum bleeding is "just gingivitis" without asking about anticoagulant/antiplatelet therapy, a bleeding disorder, or other systemic causes when the pattern does not fit routine plaque-induced disease.
- Missing medication-induced gingival hyperplasia because the medication list was not specifically reviewed for phenytoin, cyclosporine, or a calcium channel blocker.[9]
- Suggesting a patient stop or switch phenytoin, cyclosporine, or a calcium channel blocker unilaterally rather than raising it with the prescriber.
- Treating necrotizing gingivitis as ordinary gingivitis and delaying dental referral — the punched-out papillae, grey pseudomembrane, and fetid breath pattern is a distinct, more urgent condition.[11]
- Failing to recognize that any reported gum recession, tooth mobility, or pocketing means the case is no longer simple gingivitis and needs a formal periodontal assessment.[3]
- Overlooking pregnancy or diabetes as contributing factors and missing a genuinely useful counselling opportunity in either group.
- Assuming a smoker's less-dramatic-looking bleeding on probing means healthier gums — nicotine-related vasoconstriction can mask the usual warning sign, so smokers deserve closer attention, not less.[6]
Clinical Decision Algorithm
Drug Tables
How to use this table: Mouth-rinse doses are standard adult doses; confirm against the product's own labelling. Antibiotic and analgesic doses require patient-specific confirmation (renal/hepatic function, weight, allergy history, pregnancy status). Drug pricing is intentionally omitted. Select any linked drug name to open its complete Pharmasist Drug Database page.
Mouth Rinses
Adjuncts to mechanical plaque removal, not substitutes for it — see Non-Pharmacologic Management.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Chlorhexidine gluconate 0.12% oral rinse | Adults: 15 mL undiluted, rinse 30 seconds twice daily after brushing; avoid rinsing/eating/drinking for about 30 minutes afterward Children: Safety/efficacy not fully established — weigh benefit against risk on a dentist-directed basis | Reversible brown/yellow staining of teeth, restorations, and tongue; taste alteration (most patients accommodate with continued use, rare permanent cases reported); increased supragingival calculus; epithelial irritation/desquamation reported in children; rare parotid gland swelling | Do not use with, or rinse immediately after, other mouthwashes or water — reduces effectiveness; not to be mixed/diluted with any other product | Health Canada-approved for moderate-to-severe gingivitis as part of a professional program. Initial course 3 months, then dental recall to evaluate, remove stain, and decide on continuation. |
| Essential-oil rinse (thymol/eucalyptol/menthol-type) | Adults: Approximately 20 mL rinsed for 30 seconds twice daily per product labelling | Transient burning sensation; alcohol-containing formulations may cause taste/mucosal irritation | None significant at standard use | Alcohol-free formulations are available; a modest edge over cetylpyridinium chloride rinses at 3 and 6 months in comparative trials. |
| Cetylpyridinium chloride (CPC) rinse | Adults: Rinse 20-30 seconds twice daily per product labelling | Generally well tolerated; occasional transient staining or taste alteration with prolonged use | None significant at standard use | A reasonable OTC alternative to an essential-oil rinse; both are adjuncts, not substitutes for brushing and flossing. |
Necrotizing Gingivitis — Antibiotics and Analgesia
Used alongside dentist-performed debridement and a twice-daily 0.12% chlorhexidine rinse, not as stand-alone therapy. Reserve systemic antibiotics for fever, malaise, or other systemic involvement.
| Drug | Dosage | Adverse effects | Drug interactions | Comments |
|---|---|---|---|---|
| Metronidazole | Adults: Per the product's own Drug Database monograph | GI upset, metallic taste, disulfiram-like reaction with alcohol | Avoid alcohol during and for 24-48 hours after use | First-line systemic antibiotic option when systemic symptoms are present. |
| Amoxicillin / clavulanic acid | Adults: Per the product's own Drug Database monograph | GI upset, diarrhea, hypersensitivity | May increase INR with warfarin; may increase methotrexate levels | Alternative first-line systemic antibiotic option. |
| Ibuprofen | Adults: 400-600 mg PO 3 times daily as needed | GI upset/bleeding risk, renal effects with prolonged use | Increased bleeding risk with anticoagulants; avoid with other NSAIDs | Reflects the genuine pain of necrotizing gingivitis specifically — significant pain is not typical of ordinary gingivitis and should itself prompt reconsidering the diagnosis. |
Representative Medications Causing Gingival Hyperplasia, by Class
Not a treatment table — these are causative medications flagged during a medication review, not agents to recommend. Never stop or switch any of these unilaterally; raise a medication-review conversation with the prescriber. See Risk Factors and Special Populations for the full discussion.
| Drug | Reported prevalence of gingival overgrowth | Typical tissue appearance |
|---|---|---|
| Phenytoin | Up to 50% of patients on long-term therapy | Predominantly fibrotic |
| Cyclosporine | Roughly 30% of patients | More inflamed, less fibrotic |
| Nifedipine | Roughly 20% of patients | Mixed fibrotic/inflammatory |
| Amlodipine | Reported since 1994; exact prevalence less well characterized than nifedipine | Mixed fibrotic/inflammatory, same class mechanism as nifedipine |
References
- Gingivitis — Canadian Dental Association, Your Oral Health. CDA Your Oral Health
- Gum Diseases FAQs — Canadian Dental Association. CDA Your Oral Health, FAQs
- A new classification scheme for periodontal and peri-implant diseases and conditions — Journal of Periodontology (Caton JG, Armitage G, Berglundh T, Chapple ILC, Jepsen S, Kornman KS, et al.). J Periodontol 2018;89(Suppl 1):S1-S8
- Gingivitis — American Dental Association, MouthHealthy. ADA MouthHealthy
- Gum Disease - Periodontal Disease — American Dental Association, MouthHealthy. ADA MouthHealthy
- The Influence of Cigarette Smoking on Gingival Bleeding and Serum Concentrations of Haptoglobin and Alpha 1-Antitrypsin — BioMed Research International (Al-Bayaty FH, Arkilla MB, Al-Bayaty MF). BioMed Res Int 2013
- An umbrella review of systematic reviews examining the relationship between type 2 diabetes and periodontitis: Position paper from the Canadian Dental Hygienists Association — Canadian Journal of Dental Hygiene (Lavigne SE, Forrest JL). Can J Dent Hyg 2021;55(1):57-67
- Oral health during pregnancy — American Family Physician (Silk H, Douglass AB, Douglass JM, Silk L). Am Fam Physician 2008;77(8):1139-1144
- Drug-Induced Gingival Overgrowth — StatPearls (Tungare S, Paranjpe AG). StatPearls Publishing, updated September 19, 2022
- Caries Prevention for Patients with Dry Mouth — Journal of the Canadian Dental Association (Su N, Marek CL, Ching V, Grushka M). J Can Dent Assoc 2011;77:b85
- Managing Patients with Necrotizing Ulcerative Gingivitis — Journal of the Canadian Dental Association. J Can Dent Assoc
- PERIDEX Oral Rinse (Chlorhexidine Gluconate Oral Rinse 0.12%) Product Monograph — Health Canada Drug Product Database / 3M Healthcare Canada Company Limited. Date of Preparation: October 31, 2024
- Comparative evaluation of the efficacy of cetylpyridinium chloride and essential oil mouthwashes in reducing plaque and gingivitis: a systematic review and meta-analysis — Evidence-Based Dentistry (Mohapatra S, Mohandas R). Evid Based Dent 2025
Professional reference only. Apply clinical judgment and verify patient-specific decisions against current authoritative guidance and product information.